BSECompany Update1d ago · 31 Aug 2026, 05:56 pm
Schedule of Investor Meets
Gland Pharma Ltd · 543245
✦ AI Summary
Gland Pharma Ltd has announced a schedule of investor meets under Regulation 30 of LODR, intimating the same to the exchanges. The meets are scheduled from September 3 to November 22, 2022, and will be attended by the company's management. The meets are subject to change and may be affected by exigencies on the part of the investor/company.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation